CVE-2023-41089
The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, since the attack takes advantage of the cookie header to…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.52%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, since the attack takes advantage of the cookie header to generate "legitimate" requests.
- CVSS 3.1
- 8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
- EPSS
- 0.52% probability · 43th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-287
- Affected
- dexma/dexgate
- Source
- ics-cert@hq.dhs.gov
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.